Drugs like Ozempic could prove costly for benefit plans – but also mean healthier employees
![Should employers cover GLP-1 drugs for obesity?](https://cdn-res.keymedia.com/cdn-cgi/image/f=auto/https://cdn-res.keymedia.com/cms/images/ca/126/0379_638445788553907794.jpg)
“Ozempic” filled many headlines in 2023, as the GLP-1 drug has proven effective and popular when it comes to weight loss – despite its original mandate being focused on diabetes.